Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 10, 1998

View Archived Issues

Allelix: Q3 1998 highlights

Exelon demonstrates robust effects on cognitive function in Alzheimer's disease patients

Sugen reaches milestone in collaborative agreement with Allergan

Oral aciclovir therapy reduces recurrence of herpes infection of the eye

Gene screening technology developed at Harvard Medical School licensed to Versicor

Molecular Biosystems: Q1 fiscal 1999 highlights

Single-antigen pertussis vaccine approved by FDA

Duramed receives FDA approval for hydroxyurea capsules

A significant portion of heart attack patients still do not receive proper medication

Negative interaction reported: cimetidine prolongs clarithromycin absorption

FluMist protects against influenza infection in second year of two-year study

Incel evaluated in phase II trials for the treatment of prostate cancer

Icos: Q2 1998 highlights

Roberts receives permission to launch Agrylin in Israel

Abbott discloses new antibacterial macrolides

New antiasthmatic PDE IV inhibitors revealed by Celltech

RPR reports discovery of antitumor taxoids

VivoRx discloses bifunctional paclitaxel derivatives

Searle presents new HIV protease inhibitor series

Latvian researchers discover potential new treatment for heart failure

PST-2744, an Na+/K+-ATPase inhibitor for heart failure with improved safety over digitalis

Proton pump inhibitor IY-81149 is active in models of acute and chronic gastric ulcers

Promising new antipsychotic agent in active development at Gedeon Richter

Japanese investigators study antinociceptive dynorphin analogue

European Commission approves Xenical for marketing in member countries

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...